Total Payments
$4,255
2024 Payments
$103.35
Companies
13
Transactions
22
Medicare Patients
679
Medicare Billing
$78,541
Payment Breakdown by Category
Education$3,000 (70.5%)
Food & Beverage$1,074 (25.2%)
Travel$180.48 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,000 | 1 | 70.5% |
| Food and Beverage | $1,074 | 20 | 25.2% |
| Travel and Lodging | $180.48 | 1 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,398 | 4 | $0 (2022) |
| Cumberland Pharmaceuticals, Inc. | $146.49 | 1 | $0 (2019) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2017) |
| TESARO, Inc. | $119.02 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $94.03 | 2 | $0 (2020) |
| Nuvectra Corporation | $93.82 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $82.65 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $60.30 | 3 | $0 (2019) |
| Coherus Biosciences Inc. | $34.63 | 2 | $0 (2024) |
| ViiV Healthcare Company | $29.93 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.35 | 3 | GlaxoSmithKline, LLC. ($82.65) |
| 2022 | $3,095 | 2 | Intuitive Surgical, Inc. ($3,095) |
| 2021 | $39.46 | 2 | Myriad Genetic Laboratories, Inc. ($25.53) |
| 2020 | $123.96 | 4 | Merck Sharp & Dohme Corporation ($94.03) |
| 2019 | $283.95 | 3 | Cumberland Pharmaceuticals, Inc. ($146.49) |
| 2018 | $303.27 | 6 | Intuitive Surgical, Inc. ($122.74) |
| 2017 | $305.48 | 2 | Intuitive Surgical, Inc. ($180.48) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 03/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $42.66 | General |
| 03/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 06/21/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $95.22 | General |
| Category: SURGERY | ||||||
| 03/11/2022 | Intuitive Surgical, Inc. | DAVINCI XI (Device) | Education | In-kind items and services | $3,000.00 | General |
| Category: SURGERY | ||||||
| 11/17/2021 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $25.53 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 03/29/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/30/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: HIV | ||||||
| 03/03/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $73.24 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: HIV | ||||||
| 10/02/2019 | Cumberland Pharmaceuticals, Inc. | Caldolor (Drug) | Food and Beverage | In-kind items and services | $146.49 | General |
| Category: Anesthesiology (Pain Management) | ||||||
| 06/06/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $119.02 | General |
| Category: ONCOLOGY | ||||||
| 03/29/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Oncology | ||||||
| 10/18/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Oncology | ||||||
| 10/11/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2018 | Amgen Inc. | Nplate (Biological), Prolia, XGEVA | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Hematology | ||||||
| 05/02/2018 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $122.74 | General |
| Category: SURGERY | ||||||
| 03/08/2018 | Nuvectra Corporation | Algovita (Device) | Food and Beverage | In-kind items and services | $93.82 | General |
| Category: IMPLANTED SPINAL-CORD STIMULATOR FOR PAIN RELIEF | ||||||
| 01/18/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Oncology | ||||||
| 06/15/2017 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: BioOncology | ||||||
| 01/21/2017 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $180.48 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 251 | 348 | $148,691 | $32,652 |
| 2022 | 7 | 141 | 154 | $56,553 | $18,375 |
| 2021 | 3 | 109 | 150 | $40,855 | $12,844 |
| 2020 | 3 | 178 | 226 | $58,091 | $14,670 |
Total Patients
679
Total Services
878
Medicare Billing
$78,541
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 170 | $57,984 | $12,937 | 22.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $42,680 | $9,696 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 48 | $23,093 | $4,861 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $12,459 | $2,831 | 22.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 33 | $7,122 | $1,552 | 21.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 21 | 25 | $5,354 | $775.36 | 14.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 34 | 34 | $21,165 | $6,330 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 34 | $10,783 | $3,676 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $10,451 | $3,036 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $5,700 | $2,118 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 25 | $5,404 | $1,976 | 36.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $1,586 | $646.64 | 40.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 11 | 12 | $1,464 | $592.80 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 84 | 125 | $32,000 | $10,243 | 32.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $6,684 | $1,864 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 13 | $2,171 | $736.58 | 33.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 100 | 141 | $36,096 | $9,276 | 25.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 20 | 20 | $11,140 | $2,853 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 58 | 65 | $10,855 | $2,542 | 23.4% |
About Dr. Amy Hakim, MD
Dr. Amy Hakim, MD is a Gynecology healthcare provider based in Mission Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093909228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Hakim, MD has received a total of $4,255 in payments from pharmaceutical and medical device companies, with $103.35 received in 2024. These payments were reported across 22 transactions from 13 companies. The most common payment nature is "Education" ($3,000).
As a Medicare-enrolled provider, Hakim has provided services to 679 Medicare beneficiaries, totaling 878 services with total Medicare billing of $78,541. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Gynecologic Oncology
- Location Mission Hills, CA
- Active Since 08/30/2007
- Last Updated 11/15/2023
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1093909228
Products in Payments
- DAVINCI XI (Device) $3,000
- Da Vinci Surgical System (Device) $398.44
- Caldolor (Drug) $146.49
- Avastin (Biological) $125.00
- ZEJULA (Drug) $119.02
- KEYTRUDA (Biological) $94.03
- Algovita (Device) $93.82
- LYNPARZA (Drug) $60.30
- Udenyca (Biological) $34.63
- DOVATO (Drug) $29.93
- Nplate (Biological) $29.04
- myRisk (Device) $25.53
- FOUNDATIONONE (Device) $15.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.